Has Ali Namazi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $38,383 in general payments to Ali Namazi, MD across 682 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ali Namazi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ali Namazi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ali Namazi, MD

Cardiovascular Disease · Las Vegas, NVNPI 1649530858

Payments from drug & device makers

$38,383in general payments, 2019–2025

Across 682 payments — averaging $56.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$13K
Biosense Webster, Inc.$7K
Medtronic$6K
Boston Scientific$4K
Philips North America LLC$854
Abiomed$656
plus $6K from 36 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	105	$13,368
Biosense Webster, Inc.	188	$7,248
Medtronic(2 entities)	76	$5,979
Boston Scientific	99	$4,198
Philips North America LLC	6	$854
Abiomed	8	$656
Novartis	37	$655
Medical Device Business Services, Inc.	3	$616
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	15	$474
Impulse Dynamics (USA) Inc.	3	$414
Cardiva Medical, Inc.	25	$407
Kestra Medical Technology Services, Inc.	15	$392
E.r. Squibb & Sons, L.L.C.	14	$340
Elutia, Inc.	3	$271
Biotronik Inc.	2	$270
Johnson & Johnson(2 entities)	13	$208
AstraZeneca	5	$183
Lantheus Medical Imaging, Inc.	8	$176
Cvrx, Inc.	1	$144
Merck	7	$142
Bridgebio Pharma, Inc.	6	$140
Novo Nordisk	7	$136
Scpharmaceuticals Inc.	1	$127
Actelion Pharmaceuticals US, Inc.	1	$117
Pfizer	6	$103
ZOLL Respicardia, Inc.	1	$92
Alnylam Pharmaceuticals Inc.	3	$90
Atricure, Inc.	2	$60
Baxter Healthcare	2	$55
Amgen	3	$53
Bayer	2	$52
Cleerly, Inc.	1	$50
Boehringer Ingelheim	2	$47
Esperion Therapeutics, Inc.	1	$43
Bard Peripheral Vascular, Inc.	2	$41
Sanofi-aventis U.S. LLC	2	$40
Kiniksa Pharmaceuticals, Ltd.	2	$32
Edwards Lifesciences	1	$28
Lexicon Pharmaceuticals, Inc.	1	$27
Cardiofocus, Inc.	1	$24
Chiesi USA, Inc.	1	$17
Kowa Pharmaceuticals America, Inc.	1	$15

How this compares

$38,383 in reported general payments places this provider in the 85th percentile of 165 cardiovascular disease providers in Nevada.

See all cardiovascular disease providers in Nevada →

Medicare billing

Part B allowed, 2024

$405,012

Medicare patients

1,553

Services billed

4,778

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Las Vegas

Ramprasad DandillayaLas Vegas$1.8M
Chowdhury AhsanLas Vegas$1.4M
Arjun GururajLas Vegas$399K
Navid KazemiLas Vegas$156K
Branavan UmakanthanLas Vegas$109K
Sanjay MalhotraLas Vegas$101K
Jawad KianiLas Vegas$73K
Amish PrasadLas Vegas$58K
Rafael ValenciaLas Vegas$52K
Salvador BorromeoLas Vegas$45K

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →